Literature DB >> 26336867

Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements.

Jeanette C Mostert1,2, A Marten H Onnink3, Barbara Franke1,3, Martine Hoogman1, Marieke Klein1, Janneke Dammers1,3, Anais Harneit1, Theresa Schulten1, Kimm J E van Hulzen1,2, Cornelis C Kan3, Dorine Slaats-Willemse4, Jan K Buitelaar4,5.   

Abstract

Attention Deficit/Hyperactivity Disorder (ADHD) in childhood is associated with impaired functioning in multiple cognitive domains: executive functioning (EF), reward and timing. Similar impairments have been described for adults with persistent ADHD, but an extensive investigation of neuropsychological functioning in a large sample of adult patients is currently lacking. We systematically examined neuropsychological performance on tasks measuring EF, delay discounting, time estimation and response variability using univariate ANCOVA's comparing patients with persistent ADHD (N=133, 42% male, mean age 36) and healthy adults (N=132, 40% male, mean age 36). In addition, we tested which combination of variables provided the highest accuracy in predicting ADHD diagnosis. We also estimated for each individual the severity of neuropsychological dysfunctioning. Lastly, we investigated potential effects of stimulant medication and a history of comorbid major depressive disorder (MDD) on performance. Compared to healthy adults, patients with ADHD showed impaired EF, were more impulsive, and more variable in responding. However, effect sizes were small to moderate (range: 0.05-0.70) and 11% of patients did not show neuropsychological dysfunctioning. The best fitting model predicting ADHD included measures from distinct cognitive domains (82.1% specificity, 64.9% sensitivity). Furthermore, patients receiving stimulant medication or with a history of MDD were not distinctively impaired. To conclude, while adults with ADHD as a group are impaired on several cognitive domains, the results confirm that adult ADHD is neuropsychologically heterogeneous. This provides a starting point to investigate individual differences in terms of impaired cognitive pathways.
Copyright © 2015 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Adult ADHD; Executive function; Heterogeneity; Neuropsychology; Reaction time variability; Reward

Mesh:

Substances:

Year:  2015        PMID: 26336867      PMCID: PMC4788979          DOI: 10.1016/j.euroneuro.2015.08.010

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  58 in total

Review 1.  Misunderstanding analysis of covariance.

Authors:  G A Miller; J P Chapman
Journal:  J Abnorm Psychol       Date:  2001-02

2.  Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects.

Authors:  Martine Hoogman; Esther Aarts; Marcel Zwiers; Dorine Slaats-Willemse; Marlies Naber; Marten Onnink; Roshan Cools; Cornelis Kan; Jan Buitelaar; Barbara Franke
Journal:  Am J Psychiatry       Date:  2011-07-01       Impact factor: 18.112

3.  Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD.

Authors:  Damien A Fair; Deepti Bathula; Molly A Nikolas; Joel T Nigg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

4.  Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

Authors:  J J Sandra Kooij; Jan K Buitelaar; Edwin J van den Oord; Johan W Furer; Cees A Th Rijnders; Paul P G Hodiamont
Journal:  Psychol Med       Date:  2005-06       Impact factor: 7.723

5.  Neuropsychological assessment of response inhibition in adults with ADHD.

Authors:  J N Epstein; D E Johnson; I M Varia; C K Conners
Journal:  J Clin Exp Neuropsychol       Date:  2001-06       Impact factor: 2.475

6.  Neuropsychological performance in adult attention-deficit hyperactivity disorder: meta-analysis of empirical data.

Authors:  Claudia Schoechlin; Rolf R Engel
Journal:  Arch Clin Neuropsychol       Date:  2005-08       Impact factor: 2.813

Review 7.  Understanding the construct of impulsivity and its relationship to alcohol use disorders.

Authors:  Danielle M Dick; Gregory Smith; Peter Olausson; Suzanne H Mitchell; Robert F Leeman; Stephanie S O'Malley; Kenneth Sher
Journal:  Addict Biol       Date:  2010-04       Impact factor: 4.280

8.  The utility of neuropsychological tests in evaluation of Attention-Deficit/ Hyperactivity Disorder (ADHD) versus depression in adults.

Authors:  L J Katz; D S Wood; G Goldstein; R C Auchenbach; M Geckle
Journal:  Assessment       Date:  1998-03

9.  Intraindividual variability in inhibitory function in adults with ADHD--an ex-Gaussian approach.

Authors:  Dennis Gmehlin; Anselm B M Fuermaier; Stephan Walther; Rudolf Debelak; Mirjam Rentrop; Celina Westermann; Anuradha Sharma; Lara Tucha; Janneke Koerts; Oliver Tucha; Matthias Weisbrod; Steffen Aschenbrenner
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

10.  Multiple deficits in ADHD: executive dysfunction, delay aversion, reaction time variability, and emotional deficits.

Authors:  Douglas Sjöwall; Linda Roth; Sofia Lindqvist; Lisa B Thorell
Journal:  J Child Psychol Psychiatry       Date:  2012-10-15       Impact factor: 8.982

View more
  33 in total

1.  Methylphenidate increases willingness to perform effort in adults with ADHD.

Authors:  Merideth A Addicott; Julia C Schechter; Jeffrey J Sapyta; James P Selig; Scott H Kollins; Margaret D Weiss
Journal:  Pharmacol Biochem Behav       Date:  2019-06-18       Impact factor: 3.533

2.  Attention-Deficit/Hyperactivity Disorder and Monetary Delay Discounting: A Meta-Analysis of Case-Control Studies.

Authors:  Jacob N S Jackson; James MacKillop
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-02-11

3.  Sluggish Cognitive Tempo Symptoms Contribute to Heterogeneity in Adult Attention-Deficit Hyperactivity Disorder.

Authors:  Jaclyn M Kamradt; Allison M Momany; Molly A Nikolas
Journal:  J Psychopathol Behav Assess       Date:  2017-10-28

4.  Similar Subgroups Based on Cognitive Performance Parse Heterogeneity in Adults With ADHD and Healthy Controls.

Authors:  Jeanette C Mostert; Martine Hoogman; A Marten H Onnink; Daan van Rooij; Daniel von Rhein; Kimm J E van Hulzen; Janneke Dammers; Cornelis C Kan; Jan K Buitelaar; David G Norris; Barbara Franke
Journal:  J Atten Disord       Date:  2015-09-14       Impact factor: 3.256

5.  Basic processes as foundations of cognitive impairment in adult ADHD.

Authors:  Marah Butzbach; Anselm B M Fuermaier; Steffen Aschenbrenner; Matthias Weisbrod; Lara Tucha; Oliver Tucha
Journal:  J Neural Transm (Vienna)       Date:  2019-07-18       Impact factor: 3.575

6.  Using Repeated-Measures Data to Make Stronger Tests of the Association between Executive Function Skills and Attention Deficit/Hyperactivity Disorder Symptomatology in Early Childhood.

Authors:  Michael T Willoughby; Amanda C Wylie; Clancy B Blair
Journal:  J Abnorm Child Psychol       Date:  2019-11

7.  Attention as neurocognitive endophenotype of ADHD across the life span: a family study.

Authors:  Sara Boxhoorn; Eva Lopez; Catharina Schmidt; Diana Schulze; Susann Hänig; Hannah Cholemkery; Christine M Freitag
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-05-08       Impact factor: 5.270

Review 8.  Cognitive characterization of adult attention deficit hyperactivity disorder by domains: a systematic review.

Authors:  Iban Onandia-Hinchado; Natividad Pardo-Palenzuela; Unai Diaz-Orueta
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575

Review 9.  Treatment of adult ADHD: a clinical perspective.

Authors:  Josh Geffen; Kieran Forster
Journal:  Ther Adv Psychopharmacol       Date:  2017-10-25

Review 10.  Linking ADHD to the Neural Circuitry of Attention.

Authors:  Adrienne Mueller; David S Hong; Steven Shepard; Tirin Moore
Journal:  Trends Cogn Sci       Date:  2017-05-05       Impact factor: 20.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.